Carsten Eberhardt

Sales And Marketing Director DACH at Flen Health

Carsten Eberhardt is an experienced sales professional in the healthcare sector, currently serving as Sales Director D-A-CH at Flen Health since March 2023. Prior to this role, Carsten had an extensive tenure at Medela from May 2009 to February 2023, where responsibilities included leading the B2C sales team, managing key accounts such as Amazon and various pharmacy chains, and serving on the executive board. Carsten's earlier roles included positions in key account management and sales representation across multiple companies, including Kettenbach and Karmed GmbH, with a focus on medical devices and homecare. Carsten's educational background includes qualifications in healthcare and business management, equipping with strong expertise in both sales and the healthcare industry.

Location

Tübingen, Germany

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Flen Health

Flen Health Live the Life you love! Flen Health believes biotech innovations can help to build a securer life for you and for every human being. Flen Health wants to improve the quality of life of people suffering from skin disorders in a responsible way, by providing added value for patients, healthcare professionals, health authorities and the environment. Flen Health was established in 2000, building on the results of wound-treatment research performed by its managing director, Philippe Sollie, a pharmacist. Based on patented technologies, Flen Health developed and commercializes a number of innovative wound and skin healing solutions. Flen Health holds an ISO 13485 certificate that covers all its operations. Thanks to the success on the Belgian market, Flen Health initiated its international expansion. This resulted in the establishment of further affiliates across Europe (in The Netherlands, Luxembourg, UK & Germany), managed by over 100 motivated employees. Flen Health products are distributed in 25 countries all over the world. Current product portfolio: Flaminal® Hydro, Flaminal® Forte, Flamigel®, Flamigel®RT, Flamirins® and extracalm®. Direct customers are mainly healthcare professionals: Flaminal® Hydro/Forte indicated for all kind of wound treatments and Flamigel® RT for skin damage caused by radiotherapy. Flen Health continues to expand its activities and invites motivated and dynamic people to join. Feel welcome to visit our website for more information:


Employees

51-200

Links